CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

AMRUTANJAN HEALTH CARE LTD.

NSE : AMRUTANJANBSE : 590006ISIN CODE : INE098F01031Industry : Pharmaceuticals & DrugsHouse : Amrutanjan
BSE749.302.5 (+0.33 %)
PREV CLOSE () 746.80
OPEN PRICE () 730.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4538
TODAY'S LOW / HIGH ()730.15 755.05
52 WK LOW / HIGH ()556.05 802.6
NSE749.803.2 (+0.43 %)
PREV CLOSE() 746.60
OPEN PRICE () 749.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 749.80 (25)
VOLUME 18717
TODAY'S LOW / HIGH() 743.05 756.00
52 WK LOW / HIGH ()563.9 804
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1936

Management Info :

S Sambhu Prasad - Chairman S Sambhu Prasad - Managing Director

Registered Office :

Address : New 103 (Old 42-45),Luz Church Road,Mylapore,
Chennai,
Tamil Nadu-600004

Phone : 044- 24994465 / 24669000 / 18004254545

Website : www.amrutanjan.com

Registrar's Details : Cameo Corporate Services Ltd
Subramanian Buildings No 1 ,Club House Road,,Chennai
Listing : BSE, NSE, Chennai
NEWS
08May Amrutanjan Health Care informs about d
Amrutanjan Health Care has informed that the exchange has received the d..
07May Amrutanjan Health Care informs about d
Amrutanjan Health Care has informed that it enclosed disclosure under Re..
04Mar Amrutanjan Health Care informs about d
Amrutanjan Health Care has informed that it enclosed disclosure under Re..
04Mar Amrutanjan Health Care informs about d
Amrutanjan Health Care has informed that it enclosed disclosure under Re..
04Mar Amrutanjan Health Care informs about d
Amrutanjan Health Care has informed that it enclosed disclosure under Re..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit174.51398.34
Gross Profit 237.08 536.45
Operating Profit 253.38589.34
Net Sales 1169.943796.36
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 8570.70 (2.47%)
M.Cap ( in Cr)
19738.86
Astrazeneca Pharma I (BSE)
 5639.25 (2.88%)
M.Cap ( in Cr)
14098.13
Abbott India (BSE)
 26545.40 (0.42%)
M.Cap ( in Cr)
56407.12
Alkem Laboratories (BSE)
 5316.90 (1.37%)
M.Cap ( in Cr)
63571.51
Torrent Pharma (BSE)
 2703.70 (2.00%)
M.Cap ( in Cr)
91505.49
Shareholding Pattern
PROMOTERS 50.59%
NON-INSTITUTION 40.74%
MUTUAL FUNDS/UTI 6.79%
FI/BANKS/INSURANCE 0.09%
GOVERNMENT 0%
FII 0%
Mf Holding

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX73663.72676.69 (0.93%)
NIFTY22403.85203.30 (0.92%)
Dow Jones 39908.00349.89 (0.88%)
Nasdaq 16742.39231.21 (1.40%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI